Genetics of melatonin receptor type 2 is associated with left ventricular function in hypertensive patients treated according to guidelines

European Journal of Internal Medicine

Volumn 24, Issue 7, 2013, Pages 650-655

  Huber, Matthias ^a   Treszl, Andras ^b   Reibis, Rona ^a,c   Teichmann, Christopher ^a   Zergibel, Irina ^a   Bolbrinker, Juliane ^a   Scholze, Jürgen ^a   Wegscheider, Karl ^b   Völler, Heinz ^a,c,d   Kreutz, Reinhold ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Rehabilitation Center for Cardiovascular Diseases   (Germany)

^d UNIVERSITY OF POTSDAM   (Germany)

Author keywords

Clinical study; Genetics; Heart; Hypertension; Melatonin receptor type 2

Indexed keywords

MELATONIN 2 RECEPTOR;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRACTICE GUIDELINE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

CLINICAL STUDY; GENETICS; HEART; HYPERTENSION; MELATONIN RECEPTOR TYPE 2;

AGED; ECHOCARDIOGRAPHY; FEMALE; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PRACTICE GUIDELINES AS TOPIC; RECEPTOR, MELATONIN, MT1; SIGNAL TRANSDUCTION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84884280524     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.03.015     Document Type: Article

References (50)

1. R. Hardeland, D.P. Cardinali, V. Srinivasan, D.W. Spence, G.M. Brown, and S.R. Pandi-Perumal Melatonin - a pleiotropic, orchestrating regulator molecule Prog Neurobiol 93 2011 350 384
2. A. Zanoboni Experimental hypertension in pinealectomized rats Life Sci 6 1967 2327 2331
3. F. Simko, O. Pechanova, V. Pelouch, K. Krajcirovicova, P. Celec, and R. Palffy Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril J Hypertens 28 2010 S13 S18
4. E. Deniz, E. Sahna, and H.E. Aksulu Nitric oxide synthase inhibition in rats: melatonin reduces blood pressure and ischemia/reperfusion-induced infarct size Scand Cardiovasc J 40 2006 248 252
5. M. Nava, Y. Quiroz, N. Vaziri, and B. Rodriguez-Iturbe Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats Am J Physiol Renal Physiol 284 2003 F447 F454
6. F. Simko, and L. Paulis Melatonin as a potential antihypertensive treatment J Pineal Res 42 2007 319 322
7. F.A. Scheer, G.A. Van Montfrans, E.J. van Someren, G. Mairuhu, and R.M. Buijs Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension Hypertension 43 2004 192 197
8. E. Grossman, M. Laudon, R. Yalcin, H. Zengil, E. Peleg, and Y. Sharabi Melatonin reduces night blood pressure in patients with nocturnal hypertension Am J Med 119 2006 898 902
9. A. Cagnacci, M. Cannoletta, A. Renzi, F. Baldassari, S. Arangino, and A. Volpe Prolonged melatonin administration decreases nocturnal blood pressure in women Am J Hypertens 18 2005 1614 1618
10. A. Dominguez-Rodriguez Melatonin in cardiovascular disease Expert Opin Investig Drugs 21 2012 1593 1596
11. E. Sahna, H. Parlakpinar, Y. Turkoz, and A. Acet Protective effects of melatonin on myocardial ischemia/reperfusion induced infarct size and oxidative changes Physiol Res 54 2005 491 495
12. R.J. Reiter, and D.X. Tan Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart Cardiovasc Res 58 2003 10 19
13. D.X. Tan, L.C. Manchester, R.J. Reiter, W. Qi, S.J. Kim, and G.H. El-Sokkary Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin J Pineal Res 25 1998 184 191
14. H.M. Yeung, M.W. Hung, and M.L. Fung Melatonin ameliorates calcium homeostasis in myocardial and ischemia-reperfusion injury in chronically hypoxic rats J Pineal Res 45 2008 373 382
15. S.M. Reppert, C. Godson, C.D. Mahle, D.R. Weaver, S.A. Slaugenhaupt, and J.F. Gusella Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor Proc Natl Acad Sci U S A 92 1995 8734 8738
16. M.L. Dubocovich, P. Delagrange, D.N. Krause, D. Sugden, D.P. Cardinali, and J. Olcese International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors Pharmacol Rev 62 2010 343 380
17. R.J. Reiter, L.C. Manchester, L. Fuentes-Broto, and D.X. Tan Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin J Hypertens 28 2010 S7 S12
18. C. Ekmekcioglu, T. Thalhammer, S. Humpeler, M.R. Mehrabi, H.D. Glogar, and T. Holzenbein The melatonin receptor subtype MT2 is present in the human cardiovascular system J Pineal Res 35 2003 40 44
19. M.K. Irmak, and A. Sizlan Essential hypertension seems to result from melatonin-induced epigenetic modifications in area postrema Med Hypotheses 66 2006 1000 1007
20. T. Sparso, A. Bonnefond, E. Andersson, N. Bouatia-Naji, J. Holmkvist, and L. Wegner G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans Diabetes 58 2009 1450 1456
21. H. Staiger, F. Machicao, S.A. Schafer, K. Kirchhoff, K. Kantartzis, and M. Guthoff Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function PLoS One 3 2008 e3962
22. M. Volpe, J. Camm, A. Coca, and T. Unger The cardiovascular continuum refined: a hypothesis Blood Press 19 2010 273 277
23. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee J Hypertens 17 1999 151 183
24. R. Cifkova, S. Erdine, R. Fagard, C. Farsang, A.M. Heagerty, and W. Kiowski Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines J Hypertens 21 2003 1779 1786
25. R. Ekart, M. Bernhardt, B.P. Balon, S. Bevc, and R. Hojs Forty-eight-hour ambulatory blood pressure and carotid-femoral pulse wave velocity in hemodialysis patients Ther Apher Dial 15 2011 273 277
26. A.S. Levey, J. Coresh, E. Balk, A.T. Kausz, A. Levin, and M.W. Steffes National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Ann Intern Med 139 2003 137 147
27. M. Stephens, N.J. Smith, and P. Donnelly A new statistical method for haplotype reconstruction from population data Am J Hum Genet 68 2001 978 989
28. M. Stephens, and P. Scheet Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation Am J Hum Genet 76 2005 449 462
29. S. Wellek, K.A. Goddard, and A. Ziegler A confidence-limit-based approach to the assessment of Hardy-Weinberg equilibrium Biom J 52 2010 253 270
30. G. de Simone, R.B. Devereux, S.R. Daniels, M.J. Koren, R.A. Meyer, and J.H. Laragh Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk J Am Coll Cardiol 25 1995 1056 1062
31. D.J. Lefer, and D.N. Granger Oxidative stress and cardiac disease Am J Med 109 2000 315 323
32. S. Tengattini, R.J. Reiter, D.X. Tan, M.P. Terron, L.F. Rodella, and R. Rezzani Cardiovascular diseases: protective effects of melatonin J Pineal Res 44 2008 16 25
33. M. Ersahin, O. Sehirli, H.Z. Toklu, S. Suleymanoglu, E. Emekli-Alturfan, and A. Yarat Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension J Pineal Res 47 2009 97 106
34. E. Grossini, C. Molinari, F. Uberti, D.A. Mary, G. Vacca, and P.P. Caimmi Intracoronary melatonin increases coronary blood flow and cardiac function through beta-adrenoreceptors, MT1/MT2 receptors, and nitric oxide in anesthetized pigs J Pineal Res 51 2011 246 257
35. G. Ghosh, K. De, S. Maity, D. Bandyopadhyay, S. Bhattacharya, and R.J. Reiter Melatonin protects against oxidative damage and restores expression of GLUT4 gene in the hyperthyroid rat heart J Pineal Res 42 2007 71 82
36. F. Simko, O. Pechanova, V. Pelouch, K. Krajcirovicova, M. Mullerova, and K. Bednarova Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats J Hypertens Suppl 27 2009 S5 S10
37. F. Simko, and O. Pechanova Remodelling of the heart and vessels in experimental hypertension: advances in protection J Hypertens 28 2010 S1 S6
38. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, E. Arroyo-Ucar, and R.J. Reiter Decreased level of melatonin in serum predicts left ventricular remodelling after acute myocardial infarction J Pineal Res 53 2012 319 323
39. J.T. Laitinen, G. Flugge, and J.M. Saavedra Characterization of melatonin receptors in the rat area postrema: modulation of affinity with cations and guanine nucleotides Neuroendocrinology 51 1990 619 624
40. A. Seltzer, M. Viswanathan, and J.M. Saavedra Melatonin-binding sites in brain and caudal arteries of the female rat during the estrous cycle and after estrogen administration Endocrinology 130 1992 1896 1902
41. C.D. Clemente, J. Sutin, and J.T. Silverstone Changes in electrical activity of the medulla on the intravenous injection of hypertonic solutions Am J Physiol 188 1957 193 198
42. L.M. Williams, L.T. Hannah, M.H. Hastings, and E.S. Maywood Melatonin receptors in the rat brain and pituitary J Pineal Res 19 1995 173 177
43. L. Paulis, and F. Simko Blood pressure modulation and cardiovascular protection by melatonin: potential mechanisms behind Physiol Res 56 2007 671 684
44. L. Pogan, P. Bissonnette, L. Parent, and R. Sauve The effects of melatonin on Ca(2 +) homeostasis in endothelial cells J Pineal Res 33 2002 37 47
45. V. Lyssenko, C.L. Nagorny, M.R. Erdos, N. Wierup, A. Jonsson, and P. Spegel Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion Nat Genet 41 2009 82 88
46. G.B. Ehret, P.B. Munroe, K.M. Rice, M. Bochud, A.D. Johnson, and D.I. Chasman Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk Nature 478 2011 103 109
47. E.R. Fox, S.K. Musani, M. Barbalic, H. Lin, B. Yu, and K.O. Ogunyankin Genome-Wide Association Study of Cardiac Structure and Systolic Function in African Americans: The Candidate Gene Association Resource (CARe) Study Circ Cardiovasc Genet 2012 10.1161/CIRCGENETICS.111.962365
48. P. Gudmundsson, E. Rydberg, R. Winter, and R. Willenheimer Visually estimated left ventricular ejection fraction by echocardiography is closely correlated with formal quantitative methods Int J Cardiol 101 2005 209 212
49. C.D. Patel, M.R. Nadig, S. Kurien, S. Barai, R. Narang, and A. Malhotra Left ventricular ejection fraction and volumes on rest gated 201Tl perfusion SPECT: comparison with two-dimensional echocardiography Nucl Med Commun 27 2006 425 429
50. C. Li, D. Lossnitzer, H.A. Katus, and S.J. Buss Comparison of left ventricular volumes and ejection fraction by monoplane cineventriculography, unenhanced echocardiography and cardiac magnetic resonance imaging Int J Cardiovasc Imaging 28 2012 1003 1010